Markus Suter Email and Phone Number

• Developed a framework for low- and middle-income countries to assess their readiness to address cardiovascular disease, and provided them with a long list of potential initiatives to improve their readiness• Created a Patient Affordability Program (PAP) framework for global use in a leading pharma company to ensure sustainable access to new therapies • Supported the organization of the business account for a top 5 pharmaceutical company at PwC on a global level

• Designed, tested, and evaluated the use of digital biomarkers in HTA assessments, which was then presented at a scientific conference• Running an advisory board for a digital Multiple Sclerosis diagnosis tool and developed and executed a market sizing tool for a client’s digital MS diagnosis tool and applied it to a novel sub-market and ultimately informed the decision of the future development focus• Conducted a systematic Real-World Evidence landscape analysis of methodologies and technologies to use in clinical trials and market applications• Evaluate the feasibility and potential of mobile vaccination clinics in several European markets (non-covid related assets)

• Support the conceptualization and development of digital tools for client advisors to improve services and sales• Support the development of the Covid-19 emergency loan repayment process